GlassScriptPhysician profile
Babak Nazer
NPI 1609035849
$123,871.37
in general payments reported to CMS, 2019-2025
14 companies · $33K in 2025
The $33K reported for 2025 was more than what 93% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $3,541 · 2021: $6,700 · 2022: $13K · 2023: $21K · 2024: $33K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $12K · Food and Beverage: $2,278 · Honoraria: $1,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $39,622.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,470.00 |
| Travel and Lodging | $12,231.67 |
| Food and Beverage | $2,277.94 |
| Honoraria | $1,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $41,441.89 | 2019-2025 | Carto 3 |
| Edwards Lifesciences Corporation | $24,912.03 | 2019-2025 | |
| Abbott Laboratories | $22,180.96 | 2019-2025 | Gallant, Tacticath Ablation Catheter, Sensor Enabled, Ensite |
| Siemens Medical Solutions USA, INC. | $20,386.27 | 2022-2025 | Acuson Origin Diagnostic Ultrasound System, Acuson Sc2000 Diagnostic Ultrasound System |
| Boston Scientific Corporation | $7,801.18 | 2021-2025 | Emblem Mri S-Icd, Sq-Rx Pulse Generator |
| Altathera Pharmaceuticals LLC | $2,880.37 | 2021-2023 | Sotalol Hydrochloride |
| Biotronik INC. | $2,275.08 | 2021 | |
| Medical Device Business Services, INC. | $1,240.81 | 2022 | |
| Pfizer INC. | $350.00 | 2022 | |
| Medtronic, INC. | $275.62 | 2024-2025 | Pulseselect, Affera Mapping System |
| Tarsus Pharmaceuticals, INC. | $87.77 | 2024 | Xdemvy |
| Cardiva Medical, INC. | $28.53 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Cardiofocus, INC. | $8.03 | 2025 | |
| Stereotaxis INC | $2.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Nazer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.